Revision Extensor Mechanism Allografting After Total Knee Arthroplasty
Gabriel E. Lewullis, MD, Jeff G. Jasko, MS, Robert E. Booth III, MD, and Jess H. Lonner, MD
Dr. Lewullis is Resident, Department of Orthopedic Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Mr. Jasko is Research Coordinator, and Drs. Booth and Lonner are Orthopedic Surgery Attendings, 3B Orthopaedics, Pennsylvania Hospital, Philadelphia, Pennsylvania.
This study analyzed the outcomes of revision extensor mechanism allografting (EMA) in 8 patients with failures of previous EMA after total knee arthroplasty. Freshfrozen allografts were used. Knee Society Clinical Rating System (KSS) scores were used to measure clinical outcomes, with special attention given to presence of extensor lag and assistive ambulatory devices. Patients were observed for an average of 3.1 years. Two patients were considered failures due to infection within the first postoperative year of the revision EMA. In the remaining6 patients, the average KSS score at most recent followup showed no improvement when compared with preoperative scores. Revisions of the failed EMA resulted in a high incidence of functional limitations, which continued to deteriorate over time.